Inventor
David Jonaitis
Inventor
Lafayette, IN, US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07DHeterocyclic compounds17%
C07BGeneral methods of organic chemistry12%
C07HSugars11%
C07CAcyclic or carbocyclic compounds9%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
C07JSteroids3%
PatentTitleYear
10,835,522Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof202010,765,693Polymorphic compounds and uses thereof202010,376,503Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof20199,974,780Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof20189,968,627Solid forms comprising 4-amino-1-b-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof20189,808,450'Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof'20179,695,146'Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof'20179,149,539'Crystalline naloxol-PEG conjugate'20159,101,642'Ticagrelor co-crystal'20159,012,469'Crystalline naloxol-peg conjugate'20158,633,243'Forms of CDDO methyl ester'20148,592,600'Solid state forms of racemic ilaprazole'20138,592,599'Solid state forms of racemic ilaprazole'20138,519,002'Colchicine solid complex; methods of making; and methods of use thereof'20138,309,601'Forms of CDDO methyl ester'20128,153,668'Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate'20128,088,824'Forms of CDDO methyl ester'20128,003,700'Colchicine solid complex; methods of making; and methods of use thereof'20117,999,110'Solid state forms of racemic ilaprazole'20117,989,632'Crystalline forms of solvated ilaprazole'20117,863,276'Salts of modulators of PPAR and methods of treating metabolic disorders'20117,858,594'Crystalline and amorphous forms of beta-L-2′-deoxythymidine'20107,605,270'Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate'20097,589,079'Crystalline and amorphous forms of beta-L-2′-deoxythymidine'20097,323,451'Crystalline and amorphous forms of beta-L-2′-deoxythymidine'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2015Based in Lafayette, IN, US· patent location history
2011–2013Patents assigned to IL YANG PHARMACEUTICAL COMPANY LTD (4)· patent assignee history
2011Based in Brookstone, IN, US· patent location history
2012–2014Patents assigned to PARENT STEPHAN D (6)· patent assignee history
2012–2014Patents assigned to JONAITIS DAVID T (5)· patent assignee history
2013–2020Based in Brookston, IN, US· patent location history
2015Patents assigned to ASTRAZENECA AB (3)· patent assignee history
2015Based in Waltham, MA, US· patent location history
2017–2020Patents assigned to CELGENE CORP (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 6 | 2017–2020 |
| PARENT STEPHAN D | 6 | 2012–2014 |
| JONAITIS DAVID Tself | 5 | 2012–2014 |
| IL YANG PHARMACEUTICAL COMPANY LTD | 4 | 2011–2013 |
| ASTRAZENECA AB | 3 | 2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Lafayette, IN, US | 14 | 2008–2015 |
| Brookston, IN, US | 9 | 2013–2020 |
| Waltham, Massachusetts, US | 1 | 2015 |
| Brookstone, IN, US | 1 | 2011 |